Solara Active Pharma Sci Share Price

₹ 634.55

-₹3.60 (-0.56%)
1D
Last updated 03 Nov, 2026, 13:10 IST
NSE: SOLARA
|
Pharmaceuticals

Solara Active Pharma Sci Share Price Today

As of 3 Nov 2026, Solara Active Pharma Sci share price is ₹634.55. The stock opened at ₹636.65, compared to its previous close of ₹638.15. During today's trading session, Solara Active Pharma Sci share price moved in the range of ₹633.10 to ₹644.45, with an average price of ₹638.78 for the day. Looking at its last 52-week, the stock has touched a low of ₹422.00 and a high of ₹774.00. On the performance front, Solara Active Pharma Sci share price has increased by 28.71% over the last six months and is up 6.39% on a year-on-year basis.

Share price over the last 1 day fell from 642.50 to 634.55, ranging between 633.35 and 643.15.
₹633.10
0.56% down today
₹644.45
1D LOW
1D HIGH

Solara Active Pharma Sci Stock Insights

Latest Earning
Op Profit TrendUp by 74.49% QoQ
Latest Earning
Net Profit TrendUp by 74.49% QoQ
Latest Earning
Revenue TrendUp by 8.74% QoQ
Stock Performance
OutperformingBeat Nifty by 28.64 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.01%
Shareholding Pattern
DIIDII decreased stake by 99.90%
Shareholding Pattern
FIIFII decreased stake by 7.02%
Solara Active Pharma Sci stock performance
Open₹636.65
High₹644.45
Low₹633.10
Prev. close₹638.15
Solara Active Pharma Sci trading activity
Volume64,356
Average traded price₹637.91
Last traded time01:10:04 03 Nov
Last traded quantity17
Circuit
L
H
₹510.55
₹765.75
52-week
L
H
₹422.00
₹774.00
Mkt Cap Cr
3,090.05
P/E
83.67
P/B
2.15
ROA
1.51%
ROE
3.3%
ROCE
6.75%
Quick Ratio
0.6
EV/EBITDA
15.52

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Solara Active has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Solara Active appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Solara Active revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Solara Active Pharma Sci Company Background

ISIN
INE624Z01016
Sector Market Cap
₹ 3,090.05 Cr

Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. It has one R&D center in Chennai.

Solara Active Pharma Sci Financial Highlights

  • Revenue: Solara Active Pharma Sci reported revenue of ₹1,375.14 crore in FY26 vs ₹1,292.08 crore in FY25. It showed an increase of 6.43% on a yearly basis.
  • Operating Profit: Solara Active Pharma Sci reported an operating loss of ₹7.41 crore in FY26 vs ₹0.54 crore in FY25. It showed a decrease of 1,472.22% on a year-on-year basis.
  • Net Profit: Solara Active Pharma Sci reported a net loss of ₹7.41 crore in FY26 vs ₹0.54 crore in FY25. It showed a decrease of 1,472.22% on a yearly basis.

Solara Active Pharma Sci Quarterly Result Highlights

  • Solara Active Pharma Sci reported revenue of ₹417.88 crore in Sep 2026, compared with ₹384.29 crore in Jun 2026, representing an increase of 8.74% on a quarter-on-quarter (QoQ) basis.
  • Solara Active Pharma Sci reported an operating profit of ₹28.46 crore in Sep 2026, compared with ₹16.31 crore in Jun 2026, representing an increase of 74.49% on a quarter-on-quarter (QoQ) basis.
  • Solara Active Pharma Sci reported a profit of ₹28.46 crore in Sep 2026, compared with ₹16.31 crore in Jun 2026, reflecting an increase of 74.49% on a QoQ basis.
  • The earnings per share (EPS) of Solara Active Pharma Sci stood at ₹1.68 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
41.93%
FII
10.71%
Other DII
0.00%
Retail and other
46.48%
Mutual funds
0.87%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 202611.59%
May 202611.33%
Jun 202611.52%
Sep 202610.71%

Solara Active Pharma Sci Investment Returns

1 day
+0.88%
1 week
+0.57%
1 month
-10.73%
1 year
+6.39%
3 years
+86.10%
5 years
-48.39%

Solara Active Pharma Sci Share Price History

Solara Active Pharma Sci share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹635.00 / ₹638.15
+0.88%
30 Oct 26
₹650.00 / ₹632.60
-3.46%
29 Oct 26
₹650.00 / ₹655.25
+0.22%
28 Oct 26
₹639.80 / ₹653.80
+2.69%
Show more

Solara Active Pharma Sci Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,368.98₹1,283.76₹1,288.92₹1,443.81
Other Income₹6.16₹8.32₹5.37₹22.55
Total Revenue₹1,375.14₹1,292.08₹1,294.29₹1,466.36
Total Expenses₹1,376.66₹1,291.54₹1,592.54₹1,511.18
Profit Before Tax-₹7.41₹0.54-₹488.42-₹44.82
Tax₹0.00₹0.00₹78.54-₹22.57
Profit After Tax-₹7.41₹0.54-₹566.96-₹22.25
EPS - Basic-₹1.68₹0.14-₹148.51-₹6.16
EPS - Diluted-₹1.68₹0.14-₹148.51-₹6.16

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹7.41₹0.54-₹488.42-₹44.82
Income before WC changes₹193.20₹210.70-₹82.66₹141.97
Change in Assets-₹79.26₹51.59₹170.45-₹13.16
Change in Liabilities₹41.09-₹48.57₹20.18₹13.90
Change in WC-₹38.17₹3.02₹190.63₹0.74
Cash flow from Operations₹152.91₹212.82₹108.87₹156.25
Cash flow from Investing-₹98.83-₹36.83-₹3.51-₹81.14
Cash flow from Financing-₹53.55-₹180.48-₹105.65-₹112.76
Total Cash Flow₹0.53-₹4.49-₹0.29-₹37.65
Cash (Start of the year)₹3.95₹8.44₹8.73₹46.38
Cash (End of the year)₹4.48₹3.95₹8.44₹8.73

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,474.49₹1,503.11₹1,550.21₹1,711.74
Current Assets₹858.10₹728.73₹800.75₹1,187.54
Total Assets₹2,332.59₹2,231.84₹2,350.96₹2,899.28
Current Liabilities₹893.91₹944.11₹1,242.85₹1,101.13
Net Current Asset-₹35.81-₹215.38-₹442.10₹86.41
Non-Current Liabilities₹183.13₹190.82₹171.53₹295.70
Equity Capital₹1,255.55₹1,096.91₹936.58₹1,502.45
Total Equity & Liabilities₹2,332.59₹2,231.84₹2,350.96₹2,899.28

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,368.98₹1,283.76₹1,288.92₹1,443.81
Other Income₹5.89₹9.14₹5.37₹22.14
Total Revenue₹1,374.87₹1,292.90₹1,294.29₹1,465.95
Total Expenses₹1,376.22₹1,293.98₹1,592.98₹1,510.73
Profit Before Tax-₹7.24-₹1.08-₹488.33-₹44.78
Tax₹0.00₹0.00₹78.54-₹22.57
Profit After Tax-₹7.24-₹1.08-₹566.87-₹22.21
EPS - Basic-₹1.64-₹0.27-₹148.38-₹6.17
EPS - Diluted-₹1.64-₹0.27-₹148.38-₹6.17

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹7.24-₹1.08-₹488.33-₹44.78
Income before WC changes₹193.44₹211.08-₹82.54₹142.10
Change in Assets-₹79.48₹51.51₹172.46-₹15.71
Change in Liabilities₹41.05-₹48.89₹20.11₹16.07
Change in WC-₹38.43₹2.62₹192.57₹0.36
Cash flow from Operations₹152.89₹212.80₹110.95₹156.17
Cash flow from Investing-₹50.14-₹36.83-₹4.66-₹81.13
Cash flow from Financing-₹102.56-₹180.48-₹106.52-₹112.76
Total Cash Flow₹0.19-₹4.51-₹0.23-₹37.72
Cash (Start of the year)₹3.81₹8.32₹8.55₹46.27
Cash (End of the year)₹4.00₹3.81₹8.32₹8.55

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,467.90₹1,496.50₹1,555.95₹1,704.08
Current Assets₹808.69₹728.60₹790.65₹1,190.87
Total Assets₹2,276.59₹2,225.10₹2,346.60₹2,894.95
Current Liabilities₹887.53₹938.07₹1,237.65₹1,096.12
Net Current Asset-₹78.84-₹209.47-₹447.00₹94.75
Non-Current Liabilities₹133.62₹190.82₹171.53₹295.70
Equity Capital₹1,255.44₹1,096.21₹937.42₹1,503.13
Total Equity & Liabilities₹2,276.59₹2,225.10₹2,346.60₹2,894.95
* All values are in INR Crore
Solara Active Pharma Sci market depth
Bid quantityBid priceAsk priceAsk quantity
7634.55634.851
3634.5634.911
12634.256351
1634.15635.0516
3634635.13
Total bid quantity26
Total ask quantity32
Solara Active Pharma Sci technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
45.42
Neutral
ATR (14)
39.51
Neutral
STOCH(9,6)
59.51
Neutral
STOCH RSI (14)
43.47
Neutral
ADX(9)
23.45
Bearish
UO(9)
44.23
Neutral
ROC(12)
-0.39
Bearish
WillR(14)
-72.71
Neutral
Period
Simple value
Exponential vaue
5D
643.3
640.3
10D
637.55
643.54
20D
651.17
653.71
50D
672.93
649.78
100D
611.35
618.12
Volume trend — traded volume by day
3 Nov0L
2 Nov1L
30 Oct1L
29 Oct1L
28 Oct2L
27 Oct3L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Solara Active Pharma Sci
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Solara Active Pharma Sci

Fund name
AUM
Aditya Birla Sun Life Manufacturing Equity Fund
0.61%
Bandhan BSE Healthcare Index Fund
0.10%
Aditya Birla Sun Life Flexi Cap Fund
0.08%

Solara Active Pharma Sci Returns Calculator

Solara Active Pharma Sci Latest News

2 weeks ago
Solara Active Pharma shares rally 16% after posting net profit of ₹28 crore in Q2 FY27; check all numbers
5 months ago
Solara shares jump over 14% after pharma giant posts ₹9.6 crore Q4 profit vs net loss; revenue up 42% YoY
Showing news item 1 of 2

Top Gainers

AEGISLOG Share Price
₹1241.50
+141.4 (+12.85%)
KRBL Share Price
₹398.50
+35.5 (+9.78%)
BALRAMCHIN Share Price
₹653.50
+53.6 (+8.93%)
MARICO Share Price
₹860.70
+62.15 (+7.78%)
CONCORDBIO Share Price
₹1238.50
+75 (+6.45%)
See more

Top Losers

KEC Share Price
₹313.70
-35.3 (-10.11%)
GNFC Share Price
₹471.20
-39.8 (-7.79%)
PRAJIND Share Price
₹258.51
-12.62 (-4.65%)
GESHIP Share Price
₹1533.50
-66.9 (-4.18%)
AIAENG Share Price
₹3486.00
-121.3 (-3.36%)
See more

Solara Active Pharma Sci Share Price FAQs

Please be aware that Solara Active Pharma Sci stock prices are subject to continuous fluctuations due to various factors.